Chris Degnan
Direttore Finanziario/CFO presso GALERA THERAPEUTICS, INC.
Patrimonio netto: 2 070 $ in data 30/04/2024
Posizioni attive di Chris Degnan
Società | Posizione | Inizio | Fine |
---|---|---|---|
GALERA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Direttore Finanziario/CFO | 21/10/2019 | - | |
Contatto Relazioni con gli Investitori | 21/10/2019 | - | |
Segretario Aziendale | 21/10/2019 | - |
Storia della carriera di Chris Degnan
Precedenti posizioni note di Chris Degnan
Società | Posizione | Inizio | Fine |
---|---|---|---|
VERRICA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 01/03/2018 | 07/10/2019 |
Direttore Finanziario/CFO | 01/03/2018 | 07/10/2019 | |
ENDO INTERNATIONAL PLC | Direttore Finanziario/CFO | 01/11/2014 | 01/03/2018 |
ASTRAZENECA PLC | Direttore Finanziario/CFO | 01/01/2004 | 01/11/2014 |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Direttore Finanziario/CFO | - | - |
Formazione di Chris Degnan
University of Notre Dame | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Irlanda | 2 |
Regno Unito | 2 |
Posizioni
Director of Finance/CFO | 5 |
Comptroller/Controller/Auditor | 2 |
Undergraduate Degree | 1 |
Settori
Health Technology | 6 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
VERRICA PHARMACEUTICALS INC. | Health Technology |
ASTRAZENECA PLC | Health Technology |
GALERA THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
- Borsa valori
- Insiders
- Chris Degnan
- Esperienza